share_log

Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Boniface John J.

Sera Prognostics | 4: Statement of changes in beneficial ownership of securities

Sera Prognostics | 4：持股變動聲明
SEC announcement ·  03/27 04:34
牛牛AI助理已提取核心訊息
John J. Boniface, Chief Scientific Officer of Sera Prognostics, completed a sale of 22,163 shares of the company's common stock on March 25, 2024. The transaction was executed at a price of $9.10 per share, resulting in a total sale value of $201,683.30. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 164,962 shares. The sale took place in an open market or private sale, according to the transaction details provided.
John J. Boniface, Chief Scientific Officer of Sera Prognostics, completed a sale of 22,163 shares of the company's common stock on March 25, 2024. The transaction was executed at a price of $9.10 per share, resulting in a total sale value of $201,683.30. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 164,962 shares. The sale took place in an open market or private sale, according to the transaction details provided.
Sera Prognostics首席科學官約翰·博尼法斯於2024年3月25日完成了22,163股公司普通股的出售。該交易以每股9.10美元的價格執行，總銷售價值爲201,683.30美元。出售後，Boniface在Sera Prognostics的直接持股量爲164,962股。根據提供的交易細節，此次出售是在公開市場或私人銷售中進行的。
Sera Prognostics首席科學官約翰·博尼法斯於2024年3月25日完成了22,163股公司普通股的出售。該交易以每股9.10美元的價格執行，總銷售價值爲201,683.30美元。出售後，Boniface在Sera Prognostics的直接持股量爲164,962股。根據提供的交易細節，此次出售是在公開市場或私人銷售中進行的。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。